Efficacy and Safety of DKM420 in Patients With Osteoarthritis of Knee
Sponsored by Dongkook Pharmaceutical Co., Ltd.
About this trial
Last updated 2 years ago
Study ID
DKM-420-MD-1
Status
Completed
Type
Interventional
Phase
N/A
Placebo
No
Accepting
40 to 80 Years
All
Not accepting
Healthy Volunteers
Trial Timing
Ended 2 years ago
What is this trial about?
To prove the non-inferiority of DKM420 by evaluating the injecting efficacy and safety DKM
420 and control for patients who have osteoarthritis of Knee.
What are the participation requirements?
Inclusion Criteria
- Men and Women who is over 40 under 80 ages.
- Diagnosed as osteoarthritis of Knee and satisfies the 3 of 6 ACR(American College of Rheumatology) conditions.
- Kellgren Lawrence grade (Ⅰ~Ⅲ) at Visit 1 or within 24 weeks.
- 100mm VAS(Visual Analogue Scale) over 40mm.
- Etc.
Exclusion Criteria
- Pregnancy and lactating women